OrphanDrug
OrphanDrug
Pharma Knowledge Base

Japan Early Conditional Approval System

PMDA Early Conditional Approval ApplicationPMD Act – Early Approval System180 days

Contents

  1. 1. Description & Eligibility
  2. 2. Countries Using This Pathway

Description & Eligibility

Japan's early conditional approval system allowing accelerated approval of certain drugs with post-marketing commitments for patients with serious unmet medical needs.

Eligibility Criteria

Serious or life-threatening condition with no locally registered alternative

Legal Reference / Source

PMDA Early Approval Guidance

Countries Using This Pathway (1)

JP
Japan
JP
Japan Early Conditional Approval System
Approval FormPMDA Early Conditional Approval Application
Timeline180 days
Legal StatusPMD Act – Early Approval System
Source Ref.PMDA Early Approval Guidance
Countries1 countries
Compliance Check
Legal Review3/11/2026
Global ValidityVerified